Cargando…
Late effects in patients with mantle cell lymphoma treated with or without autologous stem cell transplantation
Studies on late effects in patients with mantle cell lymphoma (MCL) are becoming increasingly important as survival is improving, and novel targeted drugs are being introduced. However, knowledge about late effects is limited. The aim of this population-based study was to describe the magnitude and...
| Autores principales: | , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
The American Society of Hematology
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10018432/ https://www.ncbi.nlm.nih.gov/pubmed/35973196 http://dx.doi.org/10.1182/bloodadvances.2022007241 |